EastHORN offers Pharmacovigilance support in all phases of clinical studies. Our safety team is highly experienced in the collection and evaluation of safety data and in safety reporting throughout Europe.
Founded in Prague in 2004, EastHORN is today one of the leading CROs in Europe. We operate in over 30 countries in the region with an experienced staff comprised largely of physicians and PhDs.
In January 2023 EastHORN joined Novotech, the leading Asia-Pacific centered biotech CRO, as part of Novotech global expansion program.
EastHORN’s client-base ranges from the largest global pharmaceutical companies to the smallest virtual biotechs. Since 2004 we have performed international studies in every major therapeutic area.
EastHORN builds teams that have therapeutic and country-specific expertise dedicated to achieving our clients’ goals. Thanks to this focused expertise, we are increasingly relied on to manage complex and difficult projects that may present significant challenges to other CROs based outwith our region.
EastHORN is present in more than 30 countries across Europe, from Portugal in the west across to Georgia in the east. Our locally-based staff ensure that we are experts in each country’s culture, language, logistics and healthcare systems. It is this expertise alongside long-standing relationships with sites and investigators that enables us to run complex studies on-time and on-budget.
We are an equal opportunity employer offering a friendly work environment, excellent earning potential and the opportunity to have a lifelong career with us.
In the last 5 years
We operate in over
Last Thursday, our team laced up their running shoes for an...
We are happy to invite everyone to join our webinar on the n...
Leveraging Local Relationships for Best In-Country Solutions...
EastHORN - A Novotech Company will be present this year at t...